Clinical trial

Intensity Modulated Accelerated Partial Breast Irradiation Before Surgery in Treating Older Patients With Hormone Responsive Stage 0-I Breast Cancer

NCT02186470

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2016-04-29

PhaseNA

Study timeline

Study start (actual)2016-04-29Date precision: day

Registry last updated2025-09-22

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Estrogen Receptor-positive Breast Cancerunresolved

Invasive Ductal Breast Carcinomaunresolved

Invasive Ductal Breast Carcinoma With Predominant Intraductal Componentunresolved

Medullary Ductal Breast Carcinoma With Lymphocytic Infiltrateunresolved

Mucinous Ductal Breast Carcinomaunresolved

Papillary Ductal Breast Carcinomaunresolved

Progesterone Receptor-positive Breast Cancerunresolved

Stage IA Breast Cancerunresolved

Stage IB Breast Cancerunresolved

Tubular Ductal Breast Carcinomaunresolved

Interventions

accelerated partial breast irradiationRADIATION

intensity-modulated radiation therapyRADIATION

image-guided radiation therapyRADIATION

therapeutic conventional surgeryPROCEDURE

Sponsors & collaborators

Ohio State University Comprehensive Cancer Centerlead sponsor

Mapped research locations

ColumbusOhio, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02186470 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.